Medikly, which is backed by Easton Capital, has hired Sharon Cammisa as chief customer officer. Previously, Cammisa worked at Osprey Communications where she was a partner. Based in New York, Medikly is a provider of digital marketing solutions for the pharmaceutical sector.
NEW YORK–(BUSINESS WIRE)–Medikly, a New York-based software-as-a-service (SaaS) provider of digital marketing software for the pharmaceutical industry, today announced the appointment of Sharon Cammisa as its Chief Customer Officer. The appointment is a direct reflection of Medikly’s ongoing commitment to customer success as its cloud-based marketing automation platform, MediklyOS spans more countries, customer segments, stakeholders and use cases.
“It’s a very exciting opportunity to help scale a flourishing SaaS business,” says Cammisa. “Medikly is a company that’s redefining the way pharmaceutical brands, agencies and medical publishers better integrate disparate data, media and technologies to reach, engage and understand physicians on at individual level. The scope of the opportunity and the scale of what’s possible are irresistible.”
With over 20 years of cross-functional experience in the pharmaceutical marketing space, several major domestic and global product launches under her belt, Cammisa brings deep domain expertise and experience to Medikly. Most recently as a partner at Osprey Communications, Cammisa helped grow the firm from a small video production company into a leading healthcare technology and interactive solutions agency eventually acquired by Grey Healthcare Group, a WPP agency.
“Customer experience is as important to us as it is to the pharmaceutical brands that use our platform,” said Medikly CEO and Founder Venkat Gullapalli, MD. “As our customer base continues to grow and existing customers renew, we need to expand our leadership team to match. This is why I’m excited that Sharon, with her deep domain expertise and understanding of our pharmaceutical customer needs, is coming on board as the company’s first Chief Customer Officer.”
Medikly, a Blueprint Health portfolio company, gained $1.2 million in venture funding from Easton Capital in 2013. This funding helped the company to expand its product development and SaaS capabilities, as well as increase the core team at the company’s headquarters in New York.
Medikly is pharma’s first and only unified, cloud-based platform that helps brands better reach, engage, and understand physicians across multiple touch points. Medikly’s platform goes beyond current technology solutions by delivering deeper content, interactive experiences, and a robust set of measurable and actionable big data analytics.
For more information, visit www.medikly.com.